Skip to main content
. 2022 May 6;2022:3903943. doi: 10.1155/2022/3903943

Table 7.

Effect of 90-day oral administration of LN18178 on hormones in male and female Wistar rats.

Measurements Sex LN18178 dose (mg/kg·BW)
Main groups (n = 20) Reversal groups (n = 10)
0 625 1250 2500 0 2500
T3 (ng/mL) M 0.42 ± 0.09 0.34 ± 0.07 0.44 ± 0.10 0.40 ± 0.06 0.36 ± 0.11 0.38 ± 0.15
F 0.39 ± 0.05 0.43 ± 0.09 0.33 ± 0.06 0.44 ± 0.09 0.41 ± 0.07 0.44 ± 0.14
T4 (μg/dL) M 4.00 ± 0.60 3.62 ± 0.57 3.62 ± 0.54 4.36 ± 0.73 4.20 ± 0.38 4.43 ± 0.70
F 3.11 ± 0.61 2.74 ± 0.74 3.43 ± 0.77 2.99 ± 0.39 3.46 ± 0.42 3.11 ± 0.32
TSH (ng/mL) M 1.63 ± 0.22 1.62 ± 0.24 1.57 ± 0.19 1.55 ± 0.17 1.71 ± 0.33 1.62 ± 0.27
F 1.62 ± 0.19 1.62 ± 0.18 1.56 ± 0.18 1.64 ± 0.26 1.70 ± 0.38 1.65 ± 0.26

Data are presented as mean ± SD. T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone. Each main group (n = 20; 10 male and 10 female rats); each reversal group (n = 10; 5 male and 5 female rats).